Even though FLCN’s function is not fully understood, it has been suggested that FLCN acts as a tumour suppressor gene [18] interacting with FNIP1 and FNIP2 proteins, thus playing a key role in mammalian target of rapamycin (mTOR) signalling pathway [19–21]. The gene discussed is FLCN; the disease is neoplasm.